Literature DB >> 23328568

Echocardiography in liver transplant candidates.

Anubhav Garg1, William F Armstrong.   

Abstract

Involvement of the cardiovascular system in patients with end-stage liver disease (ESLD) is well recognized and may be seen in several scenarios in adult liver transplantation (LT) candidates. The hemodynamic effects of ESLD may result in apparent heart disease, or in some instances may mask cardiac disease. Alternatively, cardiac disease can occasionally be the underlying etiology of ESLD. LT imposes significant hemodynamic stresses, with cardiovascular complications accounting for considerable perioperative mortality and morbidity. Pre-operative assessment of the cardiac status of LT candidates is thus critically important for risk stratification and management. Cardiac imaging plays an integral role in the assessment of LT candidates. In this review, we discuss the role of cardiac imaging, including transthoracic echocardiography with Doppler and contrast enhancement, noninvasive functional assessment for routine pre-operative assessment of coronary artery disease, and transesophageal echocardiography in select cases to aid in intra-operative fluid management and monitoring in LT candidates.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328568     DOI: 10.1016/j.jcmg.2012.11.002

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  19 in total

Review 1.  Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

Authors:  Robert J Donovan; Calvin Choi; Asghar Ali; Douglas M Heuman; Michael Fuchs; Anthony A Bavry; Ion S Jovin
Journal:  Dig Dis Sci       Date:  2016-11-09       Impact factor: 3.199

Review 2.  Transoesophageal echocardiography during liver transplantation.

Authors:  Lesley De Pietri; Federico Mocchegiani; Chiara Leuzzi; Roberto Montalti; Marco Vivarelli; Vanni Agnoletti
Journal:  World J Hepatol       Date:  2015-10-18

Review 3.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 5.  Evaluation of liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  James Philip G Esteban; Amon Asgharpour
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

6.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

Review 7.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

8.  Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution.

Authors:  Zrinka Sertić; Tomislav Letilović; Tajana Filipec Kanižaj; Mladen Knotek; Irzal Hadžibegović; Inga Starovečki; Helena Jerkić
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

9.  Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis.

Authors:  Ashraf Abd El-Khalik Barakat; Amna Ahmed Metwaly; Fatma Mohammad Nasr; Maged El-Ghannam; Mohamed Darwish El-Talkawy; Hoda Abu Taleb
Journal:  Electron Physician       Date:  2015-10-19

10.  Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study.

Authors:  Xiya Lu; Zhijing Wang; Liu Yang; Changqing Yang; Meiyi Song
Journal:  Front Cardiovasc Med       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.